Who Paid My Doc
Mark Williams
Optometrist, Low Vision Rehabilitation Burton, MI Doctor of Optometry
NPI 1518015759 CMS profile 947265
4067 E Court St, #10-11, Burton, MI 48509
General payments
$24
Research payments
$0
Ownership & investment interest
$0
Through program year 2020, Mark Williams of Burton, MI is reported in the CMS Open Payments database as having received $24 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 2nd percentile of Optometrist, Low Vision Rehabilitation profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2020 | General | $24 | 1 |
Beside peers
- Mark Williams
- Optometrist, Low Vision Rehabilitation median
- Middle half of Optometrist, Low Vision Rehabilitation
- National median
In program year 2025, general payments to Mark Williams were reported at $0. Among 89 Optometrist, Low Vision Rehabilitation profiles paid that year, the median was $150 and the middle half received between $50 and $382.
Show as a table
| Year | Mark Williams | Optometrist, Low Vision Rehabilitation median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $126 | $62–$303 | $163 |
| 2020 | $24 | $57 | $19–$124 | $114 |
| 2021 | $0 | $137 | $48–$277 | $132 |
| 2022 | $0 | $135 | $53–$282 | $149 |
| 2023 | $0 | $141 | $52–$361 | $160 |
| 2024 | $0 | $146 | $75–$336 | $164 |
| 2025 | $0 | $150 | $50–$382 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 1 billing codesPaid by Medicare
$713
Medicare patients
11
Services billed
11
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| Depression | 0% | |
| Alzheimer's or dementia | 0% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Optometrist, Low Vision Rehabilitation in Michigan
Alexandra Copeland
Optometrist, Low Vision Rehabilitation · Kalamazoo, MI
Ashley Peters
Optometrist, Low Vision Rehabilitation · Royal Oak, MI
Jeffrey Becraft
Optometrist, Low Vision Rehabilitation · Niles, MI
Lori Smolinski
Optometrist, Low Vision Rehabilitation · Grand Rapids, MI
Jennifer Wong
Optometrist, Low Vision Rehabilitation · Warren, MI
Laura Schnepf
Optometrist, Low Vision Rehabilitation · Battle Creek, MI
Related records
Optometrist, Low Vision Rehabilitation in Michigan
Practitioners in the same specialty and state, ranked by reported value.
All Optometrist, Low Vision Rehabilitation
Everyone recorded under this specialty, nationwide.
Doctors in Michigan
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.